Medicamen Biotech Ltd. Financials

15:43 May 30

Medicamen Biotech Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
428.20
-0.25 (-0.06%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Medicamen Biotech Ltd. Financials

Medicamen Biotech Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
428.20
-0.25 (-0.06%)
15:43 May 30
Quality
image/svg+xml

36/100
Medium Financial Strength

Valuation
image/svg+xml

22/100
Expensive Valuation

Technical

40/100
Technically Neutral

Strength

5

Weakness

14

Opportunity

1

Threats

0

5.28 %

ROE %

3.71 %

ROA %

5.60

EPS

162.79

BVPS

6.09 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM 2025
Net Sales
112.72 115.45 140.87 179.31 162.54
Operating Expenses +
93.5 91.9 116.99 157.07 148.7
Raw Material
68.42 55.69 81.8 109.54 90.65
Increase Decrease in Cost
1.04 -3.34 -9.71 -16.94 -6.02
Other Manufacturing Expense
9.74 15.1 13.9 9.41 0
Employee Cost
9 14.5 20.44 30.07 31.87
Miscellaneous Expenses
5.3 9.95 10.56 34.67 32.2
Operating Profit
19.22 23.55 23.88 22.24 13.84
Other Income
0.75 1.72 2.46 2.33 6.25
Depreciation
2.52 5.77 6.37 7.09 7.07
Interest
1.06 1.4 2.92 4.4 3.16
Profit before tax and exceptio..
16.39 18.09 17.04 13.08 9.86
Exceptional Items
0 0 0 0 0
PBT
16.39 18.09 17.04 13.08 9.86
Provision for Taxation
4.26 3.2 2.32 3.58 3.4
Net Profit
12.13 14.9 14.73 9.49 6.48
NET Profit after MI
12.13 14.9 14.84 10.93 7.59
EPS
9.93 12.19 11.92 7.5 5.11
Operating Profit Margin (%)
17.05 20.4 16.95 12.4 8.51
Net Profit Margin (%)
10.76 12.91 10.53 6.1 4.67

Medicamen Biotech Ltd. Shareholding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 43.20 43.00 43.00 43.00 43.20
FII 0.10 0.10 0.10 0.10 0.10
MF 0.00 0.00 0.00 0.00 0.00
Public 56.00 56.00 55.80 55.80 55.70
Others 0.00 0.00 0.00 0.00 0.00
Others 0.70 0.90 1.10 1.10 1.00
Shareholder Shares Holding %
Download Our App On: